September 30, 2020

Regeneron’s Covid-19 Antibody May Help Non-Hospitalized Patients Recover Faster, Early Data Show-STAT

New data from the biotechnology firm Regeneron seem likely to add to the excitement about drugs called monoclonal antibodies as treatments for Covid-19, but experts caution more data will be needed to know how potentially beneficial the medicines are. STAT, 09/29/2020